Novel Anticoagulant Peptide from Lactoferrin Binding Thrombin at the Active Site and Exosite‑I

Thrombin is currently one of the important targets for the treatment and prevention of thrombosis. At present, there are few reports on the application of lactoferrin peptides in anticoagulation. In this study, a peptide with the amino acid sequence of LRPVAAEIY (LF-LR) derived from lactoferrin was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of agricultural and food chemistry 2020-03, Vol.68 (10), p.3132-3139
Hauptverfasser: Xu, Shiqi, Fan, Fengjiao, Liu, Hanxiong, Cheng, Shuzhen, Tu, Maolin, Du, Ming
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3139
container_issue 10
container_start_page 3132
container_title Journal of agricultural and food chemistry
container_volume 68
creator Xu, Shiqi
Fan, Fengjiao
Liu, Hanxiong
Cheng, Shuzhen
Tu, Maolin
Du, Ming
description Thrombin is currently one of the important targets for the treatment and prevention of thrombosis. At present, there are few reports on the application of lactoferrin peptides in anticoagulation. In this study, a peptide with the amino acid sequence of LRPVAAEIY (LF-LR) derived from lactoferrin was shown to possess antithrombotic activity. LF-LR (5 mM) significantly prolonged activated partial thromboplastin time, prothrombin time, and thrombin time for 13.4, 1.7, and 5.1 s, respectively. It prolonged the coagulation time of fibrinogen from 15.3 ± 0.4 to 20.2 ± 0.5 s by affecting the conformation of thrombin. Using circular dichroism analysis, LF-LR can increase the α-helix content of thrombin from 25.6 to 56.7% and made the β-sheet disappear. In addition, LF-LR also quenched fluorescence of thrombin at about 346 nm (λEx = 280 nm). By means of molecular docking, it was found that LF-LR could bind to both the active site and the exosite-I of thrombin, and the combined LYS60F, TRP60D, ASP189, LYS36, and ARG77A are typical amino acids in the two domains, respectively.
doi_str_mv 10.1021/acs.jafc.9b08094
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2356604046</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2356604046</sourcerecordid><originalsourceid>FETCH-LOGICAL-a336t-3585cdee278ffda1b8e0ee99856b6f03296b33cf6cbf5540a081d3579abf852e3</originalsourceid><addsrcrecordid>eNp1kMFOGzEURS1URNK0e1bIyy6Y8DweO55lQNAiRYAEXU89nufEKBkH24Porr_QX-RLaprQXVe27HOv3juEHDOYMijZmTZx-qitmdYtKKirAzJmooRCMKY-kDFkplBCshH5GOMjACgxgyMy4iXISs34mPy48c-4pvM-OeP1cljrPtE73CbXIbXBb-hCm-QthuB6eu76zvVL-rDKP21-0ImmFdK5Se4Z6b1LSHXf0csXH_P99dfv60_k0Op1xM_7c0K-X10-XHwrFrdfry_mi0JzLlPBhRKmQyxnytpOs1YhINZ1nr6VFnhZy5ZzY6VprRAVaFCs42JW69YqUSKfkC-73m3wTwPG1GxcNLjOC6EfYlNyISVUUMmMwg41wccY0Dbb4DY6_GwYNG9em-y1efPa7L3myMm-fWg32P0LvIvMwOkO-Bv1Q-jzsv_v-wOmLoVU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2356604046</pqid></control><display><type>article</type><title>Novel Anticoagulant Peptide from Lactoferrin Binding Thrombin at the Active Site and Exosite‑I</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Xu, Shiqi ; Fan, Fengjiao ; Liu, Hanxiong ; Cheng, Shuzhen ; Tu, Maolin ; Du, Ming</creator><creatorcontrib>Xu, Shiqi ; Fan, Fengjiao ; Liu, Hanxiong ; Cheng, Shuzhen ; Tu, Maolin ; Du, Ming</creatorcontrib><description>Thrombin is currently one of the important targets for the treatment and prevention of thrombosis. At present, there are few reports on the application of lactoferrin peptides in anticoagulation. In this study, a peptide with the amino acid sequence of LRPVAAEIY (LF-LR) derived from lactoferrin was shown to possess antithrombotic activity. LF-LR (5 mM) significantly prolonged activated partial thromboplastin time, prothrombin time, and thrombin time for 13.4, 1.7, and 5.1 s, respectively. It prolonged the coagulation time of fibrinogen from 15.3 ± 0.4 to 20.2 ± 0.5 s by affecting the conformation of thrombin. Using circular dichroism analysis, LF-LR can increase the α-helix content of thrombin from 25.6 to 56.7% and made the β-sheet disappear. In addition, LF-LR also quenched fluorescence of thrombin at about 346 nm (λEx = 280 nm). By means of molecular docking, it was found that LF-LR could bind to both the active site and the exosite-I of thrombin, and the combined LYS60F, TRP60D, ASP189, LYS36, and ARG77A are typical amino acids in the two domains, respectively.</description><identifier>ISSN: 0021-8561</identifier><identifier>EISSN: 1520-5118</identifier><identifier>DOI: 10.1021/acs.jafc.9b08094</identifier><identifier>PMID: 32064873</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Amino Acid Sequence ; Animals ; Anticoagulants - chemistry ; Binding Sites ; Catalytic Domain ; Cattle ; Fibrinogen - chemistry ; Humans ; Kinetics ; Lactoferrin - chemistry ; Molecular Docking Simulation ; Peptides - chemistry ; Protein Binding ; Thrombin - chemistry ; Thrombin Time</subject><ispartof>Journal of agricultural and food chemistry, 2020-03, Vol.68 (10), p.3132-3139</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a336t-3585cdee278ffda1b8e0ee99856b6f03296b33cf6cbf5540a081d3579abf852e3</citedby><cites>FETCH-LOGICAL-a336t-3585cdee278ffda1b8e0ee99856b6f03296b33cf6cbf5540a081d3579abf852e3</cites><orcidid>0000-0001-5872-8529</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jafc.9b08094$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jafc.9b08094$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32064873$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, Shiqi</creatorcontrib><creatorcontrib>Fan, Fengjiao</creatorcontrib><creatorcontrib>Liu, Hanxiong</creatorcontrib><creatorcontrib>Cheng, Shuzhen</creatorcontrib><creatorcontrib>Tu, Maolin</creatorcontrib><creatorcontrib>Du, Ming</creatorcontrib><title>Novel Anticoagulant Peptide from Lactoferrin Binding Thrombin at the Active Site and Exosite‑I</title><title>Journal of agricultural and food chemistry</title><addtitle>J. Agric. Food Chem</addtitle><description>Thrombin is currently one of the important targets for the treatment and prevention of thrombosis. At present, there are few reports on the application of lactoferrin peptides in anticoagulation. In this study, a peptide with the amino acid sequence of LRPVAAEIY (LF-LR) derived from lactoferrin was shown to possess antithrombotic activity. LF-LR (5 mM) significantly prolonged activated partial thromboplastin time, prothrombin time, and thrombin time for 13.4, 1.7, and 5.1 s, respectively. It prolonged the coagulation time of fibrinogen from 15.3 ± 0.4 to 20.2 ± 0.5 s by affecting the conformation of thrombin. Using circular dichroism analysis, LF-LR can increase the α-helix content of thrombin from 25.6 to 56.7% and made the β-sheet disappear. In addition, LF-LR also quenched fluorescence of thrombin at about 346 nm (λEx = 280 nm). By means of molecular docking, it was found that LF-LR could bind to both the active site and the exosite-I of thrombin, and the combined LYS60F, TRP60D, ASP189, LYS36, and ARG77A are typical amino acids in the two domains, respectively.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Anticoagulants - chemistry</subject><subject>Binding Sites</subject><subject>Catalytic Domain</subject><subject>Cattle</subject><subject>Fibrinogen - chemistry</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Lactoferrin - chemistry</subject><subject>Molecular Docking Simulation</subject><subject>Peptides - chemistry</subject><subject>Protein Binding</subject><subject>Thrombin - chemistry</subject><subject>Thrombin Time</subject><issn>0021-8561</issn><issn>1520-5118</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMFOGzEURS1URNK0e1bIyy6Y8DweO55lQNAiRYAEXU89nufEKBkH24Porr_QX-RLaprQXVe27HOv3juEHDOYMijZmTZx-qitmdYtKKirAzJmooRCMKY-kDFkplBCshH5GOMjACgxgyMy4iXISs34mPy48c-4pvM-OeP1cljrPtE73CbXIbXBb-hCm-QthuB6eu76zvVL-rDKP21-0ImmFdK5Se4Z6b1LSHXf0csXH_P99dfv60_k0Op1xM_7c0K-X10-XHwrFrdfry_mi0JzLlPBhRKmQyxnytpOs1YhINZ1nr6VFnhZy5ZzY6VprRAVaFCs42JW69YqUSKfkC-73m3wTwPG1GxcNLjOC6EfYlNyISVUUMmMwg41wccY0Dbb4DY6_GwYNG9em-y1efPa7L3myMm-fWg32P0LvIvMwOkO-Bv1Q-jzsv_v-wOmLoVU</recordid><startdate>20200311</startdate><enddate>20200311</enddate><creator>Xu, Shiqi</creator><creator>Fan, Fengjiao</creator><creator>Liu, Hanxiong</creator><creator>Cheng, Shuzhen</creator><creator>Tu, Maolin</creator><creator>Du, Ming</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5872-8529</orcidid></search><sort><creationdate>20200311</creationdate><title>Novel Anticoagulant Peptide from Lactoferrin Binding Thrombin at the Active Site and Exosite‑I</title><author>Xu, Shiqi ; Fan, Fengjiao ; Liu, Hanxiong ; Cheng, Shuzhen ; Tu, Maolin ; Du, Ming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a336t-3585cdee278ffda1b8e0ee99856b6f03296b33cf6cbf5540a081d3579abf852e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Anticoagulants - chemistry</topic><topic>Binding Sites</topic><topic>Catalytic Domain</topic><topic>Cattle</topic><topic>Fibrinogen - chemistry</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Lactoferrin - chemistry</topic><topic>Molecular Docking Simulation</topic><topic>Peptides - chemistry</topic><topic>Protein Binding</topic><topic>Thrombin - chemistry</topic><topic>Thrombin Time</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, Shiqi</creatorcontrib><creatorcontrib>Fan, Fengjiao</creatorcontrib><creatorcontrib>Liu, Hanxiong</creatorcontrib><creatorcontrib>Cheng, Shuzhen</creatorcontrib><creatorcontrib>Tu, Maolin</creatorcontrib><creatorcontrib>Du, Ming</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of agricultural and food chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, Shiqi</au><au>Fan, Fengjiao</au><au>Liu, Hanxiong</au><au>Cheng, Shuzhen</au><au>Tu, Maolin</au><au>Du, Ming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel Anticoagulant Peptide from Lactoferrin Binding Thrombin at the Active Site and Exosite‑I</atitle><jtitle>Journal of agricultural and food chemistry</jtitle><addtitle>J. Agric. Food Chem</addtitle><date>2020-03-11</date><risdate>2020</risdate><volume>68</volume><issue>10</issue><spage>3132</spage><epage>3139</epage><pages>3132-3139</pages><issn>0021-8561</issn><eissn>1520-5118</eissn><abstract>Thrombin is currently one of the important targets for the treatment and prevention of thrombosis. At present, there are few reports on the application of lactoferrin peptides in anticoagulation. In this study, a peptide with the amino acid sequence of LRPVAAEIY (LF-LR) derived from lactoferrin was shown to possess antithrombotic activity. LF-LR (5 mM) significantly prolonged activated partial thromboplastin time, prothrombin time, and thrombin time for 13.4, 1.7, and 5.1 s, respectively. It prolonged the coagulation time of fibrinogen from 15.3 ± 0.4 to 20.2 ± 0.5 s by affecting the conformation of thrombin. Using circular dichroism analysis, LF-LR can increase the α-helix content of thrombin from 25.6 to 56.7% and made the β-sheet disappear. In addition, LF-LR also quenched fluorescence of thrombin at about 346 nm (λEx = 280 nm). By means of molecular docking, it was found that LF-LR could bind to both the active site and the exosite-I of thrombin, and the combined LYS60F, TRP60D, ASP189, LYS36, and ARG77A are typical amino acids in the two domains, respectively.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>32064873</pmid><doi>10.1021/acs.jafc.9b08094</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-5872-8529</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0021-8561
ispartof Journal of agricultural and food chemistry, 2020-03, Vol.68 (10), p.3132-3139
issn 0021-8561
1520-5118
language eng
recordid cdi_proquest_miscellaneous_2356604046
source MEDLINE; American Chemical Society Journals
subjects Amino Acid Sequence
Animals
Anticoagulants - chemistry
Binding Sites
Catalytic Domain
Cattle
Fibrinogen - chemistry
Humans
Kinetics
Lactoferrin - chemistry
Molecular Docking Simulation
Peptides - chemistry
Protein Binding
Thrombin - chemistry
Thrombin Time
title Novel Anticoagulant Peptide from Lactoferrin Binding Thrombin at the Active Site and Exosite‑I
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T16%3A20%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20Anticoagulant%20Peptide%20from%20Lactoferrin%20Binding%20Thrombin%20at%20the%20Active%20Site%20and%20Exosite%E2%80%91I&rft.jtitle=Journal%20of%20agricultural%20and%20food%20chemistry&rft.au=Xu,%20Shiqi&rft.date=2020-03-11&rft.volume=68&rft.issue=10&rft.spage=3132&rft.epage=3139&rft.pages=3132-3139&rft.issn=0021-8561&rft.eissn=1520-5118&rft_id=info:doi/10.1021/acs.jafc.9b08094&rft_dat=%3Cproquest_cross%3E2356604046%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2356604046&rft_id=info:pmid/32064873&rfr_iscdi=true